Using the whole-exome sequencing approach, non-synonymous mutations of human FAT1, FAT3 and FAT4 genes are detected in 1 each, and 2 out of 24 pancreatic cancer samples, respectively (53). This evidence concerns the gene FAT4 and pancreatic neoplasm.